跳到正文
HSA 治疗药品召回·· 17 天前AI 评分56

新加坡 HSA 公布 Meravo 薄膜衣片 100mg 批次 BF24003225 召回,稳定性研究结果超标

Recall of Meravo Film-coated Tablet 100mg (sacubitril, valsartan)

AI 导读

新加坡卫生科学局公布 Meravo 薄膜衣片 100mg 批次 BF24003225 的召回,召回日期为 2026 年 11 月 3 日,原因为稳定性研究出现超标结果。该召回列为 Class 2、零售层级,注册号 SIN16873P,本地公司为 Goldplus Universal Pte Ltd。HSA 要求医院、诊所和药房停止供应受影响批次,并将剩余库存退回公司。

正文 · 原文

Recall details

Date of recall:

3 November 2026

Product:

Meravo film-coated tablet 100mg

Active Ingredient:

Sacubitril, Valsartan

Product Category:

Therapeutic Product

Registration Number:

SIN16873P

Batch No.:

BF24003225

Class of Recall:

2

Level of Recall:

Retail

Local Company:

Goldplus Universal Pte Ltd

Description of Issue:

Out-of-specification results in stability study

Recall Instructions:

Hospitals, clinics, pharmacies:

Stop supplying the affected batch and return the remaining stocks to the company.

Note:   

The Health Sciences Authority (HSA) publishes information regarding recalls of health products supplied in Singapore. These product recalls may be conducted on a company’s own initiative or upon HSA’s request to remove products where there are issues with quality, safety or efficacy.   

When a recall is initiated, it does not necessarily imply that a product is considered unsafe or is inefficacious. A recall can also be initiated to remove products with quality defects that does not impact safety or efficacy from the market so as to ensure that products registered in Singapore continue to meet the stringent regulatory standards stipulated by HSA.  

Not all recalls will be publicly announced via press releases. When a recall involves a product that has been widely distributed or a product that poses a serious health risk, HSA will update the public through its channels, which may include its website, social media platforms or a press release.  

Class of recall  

A recall is classified as Class 1 or Class 2 depending on the potential hazard of the issue.  

  • Class 1: For recalls of products with issues that can potentially cause serious adverse health outcomes or death.  

  • Class 2: For recalls of products with issues that would not likely cause serious adverse health outcomes.  

Level of recall  

The level of product recall will depend on the potential hazard of the affected product, extent of distribution and whether other mitigating measures can be taken to address the issue.  

  1. Consumer level: Affected product or batch(es) recalled from patients and consumers as well as wholesale suppliers, retail suppliers, hospitals, clinics and pharmacies.  

  1. Retail level: Affected product or batch(es) recalled from retail suppliers, hospitals, clinics and pharmacies as well as wholesale suppliers.  

  1. Wholesale level: Affected product or batch(es) recalled from wholesale suppliers.  

来源:HSA 治疗药品召回 · hsa.gov.sg